Bufigen Nalbuphine Fa 100 Mg/10 Ml

Bufigen Nalbuphine Injection 10 mg/1 mL

Bufigen is the brand name for Nalbuphine Hydrochloride, a prescription opioid analgesic used for the management of moderate to severe pain. It is widely utilized in hospital and clinical settings due to its effective analgesic action and balanced safety profile. Each ampoule of Bufigen contains 10 mg of nalbuphine per 1 mL of solution, formulated for injectable use.

Mechanism of Action

Nalbuphine acts on the central nervous system by interacting with opioid receptors, where it functions as a mixed agonist–antagonist. This mechanism helps reduce the perception of pain while limiting certain opioid-related adverse effects, making it a reliable option for controlled pain management.

Indications & Clinical Use

Bufigen Nalbuphine Injection is commonly indicated for:

• Post-operative pain management

• Acute pain due to injury or trauma

• Cancer-related pain

• Pain control in palliative care settings

Its therapeutic profile supports effective pain relief while helping patients maintain comfort and quality of life during treatment and recovery.

Dosage & Administration

Bufigen 10 mg/1 mL provides an optimal balance between analgesic effectiveness and tolerability. Dosage and route of administration should be determined by a qualified healthcare professional based on the patient’s condition, pain severity, and clinical response. The medication is typically supplied in single-use ampoules.

Duration of Action & Elimination

Bufigen generally begins to act within minutes after administration, with pain relief lasting approximately 3 to 6 hours. Nalbuphine is primarily metabolized and excreted by the kidneys, with an average half-life of 2–3 hours, supporting predictable clearance from the body when used as directed.

Contraindications & Precautions

Bufigen should not be used in patients with:

• Known hypersensitivity to nalbuphine or formulation components

• Significant respiratory depression

• Individual intolerance to opioid medications

Special caution is required for pregnant individuals, elderly patients, children, and those with liver or kidney impairment. Medical supervision is essential.

Possible Side Effects

Potential side effects may include:

• Nausea or vomiting

• Drowsiness or dizziness

• Headache

• Loss of appetite

• Allergic reactions

• Rarely, loss of consciousness

Patients should seek medical advice if adverse reactions occur.

Drug Interactions

Bufigen may interact with other opioid analgesics, sedatives, antidepressants, anticonvulsants, or medications affecting liver or kidney function. Such interactions may alter analgesic efficacy or increase the risk of side effects. Always inform a healthcare provider of all current medications before use.

Bufigen Nalbuphine Injection 10 mg/1 mL is a clinically proven option for controlled pain relief in moderate to severe pain conditions. As with all prescription medications, it should be used only under medical guidance to ensure safety and effectiveness.

Bufigen Nalbuphine Fa 100mg/10ml is a trusted injectable solution designed to manage moderate to severe pain effectively. It works quickly and provides reliable relief, making it a choice for patients who require consistent pain control

How Bufigen Nalbuphine Fa Works
Explain that it’s an opioid analgesic used for pain management.

Usage and Dosage
Mention that it should only be used under medical supervision, outline the vial concentration (100mg/10ml), and highlight typical use cases (post-surgery, chronic pain, etc.).

Benefits
Reliable pain relief, fast action, widely trusted by healthcare providers.

Storage and Handling
Store in a cool, dry place, away from light.